McKinsey $207 Million Settlement: Opioid Crisis Class Action Details
Eligible claimants are General Purpose Governments, Special Districts, and other subdivisions in the U.S. that may benefit from a $207 million settlement.
Updated on
April 26, 2024
Published on
February 5, 2024
Settlement Terms
- Status:
- Award:Varies based on allocation formula
- Is Proof Required?Unknown
- Claim Deadline:Not Set
- Days Left to File Claim:
- Settlement Amount:$207,000,000
- Final Approval:
Settlement summaries by Claim Depot are written for people who might be eligible to claim class action settlement awards. Our goal is to provide the reader all relevant information about the settlement so they can claim their lawsuit funds. Claim Depot uses artificial intelligence (AI) to extract data from the vast amounts of text on the Official Settlement Website and in the court documents. Then, our writers, who are licensed attorneys, write the summary in plain English so the greater public can better understand their rights.
Case Facts
- Case Number:3:21-md-02996-CRB
- Filing Date:
- Jurisdiction:
- State:
- Court:
- Plaintiff:
- Defendant:McKinsey & Company, Inc.
- Plaintiff Firm:Robbins Geller Rudman & Dowd LLP; Bryant Law Center, PSC; Motley Rice, LLC; Simmons Hanly Conroy, LLC; Browne Pelican, PLLC
- Claims Admin:McKinsey Opiate Consultant Litigation Notice Administrator PO Box 2200 Portland, OR 97208-2200 888-575-4125 settlementinfo@rgrdlaw.com
- Defendant Firm:
Contributors
Apply Now
Settlement Agreement
Settlement Agreement
Related class action Settlements
Read more to get notified about updates to each settlement.
Open for Claims
Visa Mastercard $5.54 Billion Interchange Fee Settlement
Award:
Up to 1% of total Visa/MasterCard revenue
.svg)